-
Sanofi and Regeneron Announce FDA Approval of Dupixent (dupilumab)
biospectrumasia
April 05, 2017
Dupixent will be available later this week to U.S. patients suffering from this chronic and debilitating form of eczema
-
Regeneron and Sanofi announce FDA approval of Dupixent
cphi-online
March 31, 2017
First targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.
-
Sanofi looks to close $1 billion deal Flexion
pharmafile
March 27, 2017
According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics.
-
Sanofi CEO Olivier Brandicourt's 2017 China Visit
en-cphi
March 23, 2017
From March 18-22, Sanofi CEO Olivier Brandicourt paid his first visit to China in 2017. During the five-day trip he participated in the 2017 China Development Forum (CDF) in Beijing...
-
Sanofi exec fires back amid fight over Zika vaccine license
fiercepharma
March 23, 2017
After taking a beating over a proposed Zika vaccine license from the U.S. Army, Sanofi is hitting back.
-
Sanofi’s dupilumab receives EAMS positive scientific opinion from UK MHRA for AD
pharmaceutical-technology
March 17, 2017
UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted French pharmaceutical company Sanofi ...
-
It's a 'bad deal,' Sanders says of U.S. Army's planned Zika vaccine license to Sanofi
fiercepharma
March 16, 2017
Congressional pharma gadfly Sen. Bernie Sanders, I-Vt., is stirring up more opposition to the U.S. Army’s planned Zika vaccine transfer to Sanofi.
-
Sanofi’s dupilumab joins UK’s early access scheme
pharmatimes
March 15, 2017
Patients with atopic dermatitis are to get early access to Sanofi’s dupilumab before its marketing authorisation in the UK...
-
Sanofi, Voluntis expand agreement to deliver digital insulin titration solutions for type 2 diabetes
firstwordpharma
March 15, 2017
Sanofi and Voluntis announced Tuesday an expanded agreement to deliver digital insulin titration solutions, including a mobile phone app designed to help improve decision-making and self-management of type 2 diabetes in patients treated with basal insulin
-
AZ and Sanofi link on RSV vaccine
pharmatimes
March 06, 2017
AstraZeneca's MedImmune is partnering with Sanofi's vaccines arm Sanofi Pasteur on the development and...